Negative reactions have increased, over recent weeks, serious side effects related to the treatment tested for the emerging coronavirus “COVID-19“, reaching more than 300 cases, the French Medicines Agency (ANSM) announced, which particularly emphasizes A “wake-up signal” for hydroxychloroquine.
According to the French agency, “As of April 22, 2020, 321 cases of adverse reactions had been reported in relation to COVID-19 infection, 80% of which were serious.”
In two-thirds of cases (215 people), the pharmacological alertness survey was able to conclude that there is a potential link between the observed effect and the medications given to the patient with Covid-19.
Of these, more than half of the patients with coronaviruses were treated with hydroxychloroquine (23%) or with this drug with the antibiotic azithromycin (31%).
The agency indicated that the number of deaths observed in this context is still four, all of which are related to hydroxychloroquine and occur in hospitals.
This drug, which is derived from anti-malarial chloroquine, is known to cause electrical abnormalities in the work of the heart in some patients, and it is visible on the EKG, which can lead to disturbances of the heartbeat or even death.
The director-general of the French organization Dominique Martin explained, “It seems that patients with heart fever are more fragile in the heart and blood vessels, and therefore more likely than ordinary people to have problems with drugs harmful to the heart” such as hydroxychloroquine.
And that the side effects associated with chloroquine are mainly damaging to the liver, but also to the digestive system, heart, and kidneys.